Endothelin ET_A receptor antagonism does not attenuate angiotensin II‐induced cardiac hypertrophy in vivo in rats

This publication has 31 references indexed in Scilit:

• Synergistic Effects of AT ₁ and ET _A Receptor Blockade in a Transgenic, Angiotensin II–Dependent, Rat Model
  Hypertension, 2000
• Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy∗∗∗∗A list of participating hospitals, central agencies and personnel appears in reference 26.
  Journal of the American College of Cardiology, 2000
• Continuous Relation Between Left Ventricular Mass and Cardiovascular Risk in Essential Hypertension
  Hypertension, 2000
• Endothelin System–Dependent Cardiac Remodeling in Renovascular Hypertension
  Hypertension, 1999
• Role of Type 1 and Type 2 Angiotensin Receptors in Angiotensin II–Induced Cardiomyocyte Hypertrophy
  Hypertension, 1996
• Angiotensin II Induces Cardiac Phenotypic Modulation and Remodeling In Vivo in Rats
  Hypertension, 1995
• Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype.
  Circulation Research, 1993
• Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes.
  Journal of Clinical Investigation, 1993
• Angiotensin II Stimulation of Left Ventricular Hypertrophy in Adult Rat Heart
  American Journal of Hypertension, 1992
• Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart Study
  New England Journal of Medicine, 1990